Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis

Autor: Ferrada MA, Savic S, Collins JC, Alessi H, Gutierrez-Rodrigues F, Kumar DBU, Wilson L, Goodspeed W, Topilow JS, Paik JJ, Poulter JA, Kermani TA, Koster MJ, Warrington KJ, Cargo C, Tattersall RS, Duncan CJA, Cantor A, Hoffmann P, Payne EM, Bonnekoh H, Krause K, Cowen EW, Calvo KR, Patel BA, Ombrello AK, Kastner DL, Young NS, Werner A, Grayson PC, Beck DB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::07a317bdb05d4f8f1b32c954039fa049

(R)-albuterol decreases immune responses: role of activated T cells

Autor: Lu Xin, He Hong, Jen Kai, Gordon Erin L, Ferrada Marcela A, Barone Leesa M, Amirifeli Sepideh, Perkins David L, Finn Patricia W

Publikováno v: Respiratory Research, Vol 9, Iss 1, p 3 (2008)

Abstract Racemic albuterol is an equimolar mixture of two isomers, (R) and (S). Whether (R) and (S) isomers and the combination of both exert different effects in immune activation is not well defined. We analyzed the effects of (R+S)-albuterol, (R)-

Externí odkaz: https://doaj.org/article/6f322e6d2edf48158108c9e0e77c45a0

Análisis del discurso

Autor: Vázquez Jiménez, Lucía

Publikováno v: RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname

The use of hedging, the rule of three or conceptual metaphor among other resources, are important and very common characteristics of the language style in political speeches. Through the use of these linguistic devices, politicians can achieve severa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ea3441705fc7652dc880bccd9e6e5001
http://hdl.handle.net/10498/20019

Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.

Autor: Czech M; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Cuellar-Rodriguez J; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Patel BA; National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda, Maryland, USA., Groarke EM; National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda, Maryland, USA., Cowen EW; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Turturice B; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Beck DB; Department of Medicine and Department of Biochemistry and Molecular Pharmacology, New York University, New York, New York, USA.; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Wilson L; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Goodspeed W; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Darden I; National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda, Maryland, USA., Young NS; National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda, Maryland, USA., Hickstein D; National Heart, Blood, and Lung Institute, National Institutes of Health, Bethesda, Maryland, USA., Ombrello A; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Hoffman P; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Arikan EA; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Sinaii N; Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Hathaway L; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Castelo-Soccio L; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Fike A; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Kastner DB; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Grayson PC; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA., Ferrada MA; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jul 23; Vol. 11 (7), pp. ofae405. Date of Electronic Publication: 2024 Jul 23 (Print Publication: 2024).

Venous and arterial thrombosis in patients with VEXAS syndrome.

Autor: Kusne Y; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ., Ghorbanzadeh A; Division of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Dulau-Florea A; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Shalhoub R; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Alcedo PE; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Nghiem K; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Ferrada MA; Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD., Hines A; Department of Dermatology, Mayo Clinic, Rochester, MN., Quinn KA; Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD., Panicker SR; Laboratory of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Ombrello AK; Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD., Reichard K; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Darden I; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Goodspeed W; Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD., Durrani J; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Wilson L; Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD., Olteanu H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Lasho T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Kastner DL; Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD., Warrington KJ; Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Mangaonkar A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Go RS; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Braylan RC; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Beck DB; Laboratory of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Center for Human Genetics and Genomics, New York University School of Medicine, New York, NY., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Young NS; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Calvo KR; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Casanegra AI; Division of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Grayson PC; Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD., Koster MJ; Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Wu CO; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Kanthi Y; Laboratory of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Patel BA; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Houghton DE; Division of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Groarke EM; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Publikováno v: Blood [Blood] 2024 May 23; Vol. 143 (21), pp. 2190-2200.